VIHC Vaccine Injury Help Center Posted on January 17, 2011 by RachelB Many young women rely on a key person to help them make critical decisions in life–no matter how old you get, many turn to their mothers for advice and help. This is especially true as many head out on their own–taking their first […]
Sólo seis de cada cien niñas de 14 años se vacunaron del papiloma en 2010
La vacuna que protege del cáncer de cuello de útero y que Salud pone gratis desde 2008 no logra convencer a los padres · Las inmunizaciones han caído un 88% Granadahoy.com GRANADA | Updated 17.01.2011 – 01:00 (Google Translation) The first shot of Granada was the September 15, 2008 at the health center of La […]
Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection A Randomized Trial
JAMA. 2007;298:743-753. Main Outcome Measures Presence of HPV DNA was determinedin cervical specimins by a molecular hybridization assay usingchemiluminescence with HPV RNA probes and by polymerase chainreaction using SPF10 primers and a line probe assay detectionsystem before vaccination and by polymerase chain reaction aftervaccination. We compared rates of type-specific viral clearanceusing generalized estimating equations methods at […]
Confirmation Of High Efficacy Of HPV Vaccine Against Precancerous Cervical Lesions And Protective Effect Of Vaccination Programs
Article Date: 07 Jul 2009 – 0:00 PDT The findings of the PATRICIA study are reported in an article Online First and in a future edition of The Lancet. It shows that the HPV-16/18 AS04-adjuvanted vaccine (GlaxoSmithKline) has high efficacy against the precancerous cervical lesions that can eventually lead to cervical cancer. There is confirmation […]
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
The Lancet, Volume 374, Issue 9686, Pages 301 – 314, 25 July 2009 Background The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine was immunogenic, generally well tolerated, and effective against HPV-16 or HPV-18 infections, and associated precancerous lesions in an event-triggered interim analysis of the phase III randomised, double-blind, controlled PApilloma TRIal against Cancer In young Adults […]
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 92
- Next Page »
